Sanofi Consumer Healthcare India Limited submitted its Annual Secretarial Compliance Report for FY ended 31st December 2025, prepared by BNP & Associates, confirming full compliance with all SEBI regulations including substantial acquisition rules, insider trading prohibitions, listing obligations, and depositories regulations. The company achieved 100% compliance across 13 key regulatory areas with no violations, deviations, or regulatory actions reported during the review period.
Sanofi Consumer Healthcare India Submits Annual Secretarial Compliance Report for FY 2025
